Wordt geladen...
Oncolytic HSV-1 Virotherapy: Clinical Experience and Opportunities for Progress
Oncolytic virotherapy with mutants derived from Herpes simplex virus (HSV) type 1 exhibit significant antitumor effects in preclinical models. Several mutants have now been tested in clinical trials for a variety of cancer types, and all have been found to be safe. While there have been hints of ant...
Bewaard in:
| Gepubliceerd in: | Curr Pharm Biotechnol |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2012
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4233127/ https://ncbi.nlm.nih.gov/pubmed/21740359 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|